safety of glp 1 receptor agonists GLP-1 are increasingly used before pregnancy, but data have been limited., This meta-analysis pooled data from nearly 37,000 pregnancies and found no increased risk major GLP-1 Receptor Agonists and the

Lixisenatide reduced urinary albumin-to-creatinine ratio (UACR) versus placebo at 108 weeks of follow-up by 10% (p = 0.004)

145147 The anti-inflammatory properties of sitagliptin may help COVID-19 patients in avoiding and managing cytokine storms when administered alone or in combination with other medications such as dexamethasone, tocilizumab, or anti-IL-6 receptor antibodies

3.4 GLP-1 improves cognition by protecting neurons Some recent studies have shown that GLP-1RAs acted on the nervous system and provides neuroprotection

Despite these insights, the incidence of clinically significant muscle wasting attributable to GLP-1RA therapy remains undefined

Definition of cases and drugs of interest In the FAERS database, ADRs are classified according to the Medical Dictionary for Regulatory Activities (MedDRA) terminology in terms of signs and symptoms, which are called preferred terms (PTs)

Interestingly, these effects were found to not be simply regulated through the control of the levels of insulin (123)